← SynDRA
NEOSTIGMINE
SynDRA canonical compound SYN0000756 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ACHE |
|---|
| Mechanism of action | Acetylcholinesterase inhibitor |
|---|
| Indication | myasthenia gravis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Acetylcholinesterase inhibitor
- ACHE INHIBITOR
Drug classes
- Cholinesterase Inhibitors
- Cholinergic Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Parasympathomimetics
- Peripheral Nervous System Agents
- Cholinesterase Inhibitor
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
- N07A · PARASYMPATHOMIMETICS
Cross-references
Synonyms
- eustigmin
- eustigmine
- prostigmin
- prostigmine
- vagostigmine
- neostigmine methylsulfate
- neostigmine bromide
- Miostin
- Neostigmine (cation)
- Neostigmine cation
- Neostigmine hydroxide
- Neostigmine ion
- Eustigmin
- Eustigmine
- Intrastigmina
- Juvastigmin
- Neostigmin
- Neostigminum
- Prostigmin
- Prostigmine
- Prozerin
- Sulfonatooxymethane
- Synstigmin
- Syntostigmine
- Vagostigmin
- Vagostigmine
- Neostigmine [BAN]
- Neostigmine omega
- M-Trimethylammoniumphenyldimethylcarbamate
- Neostigmine (BAN)
- Prostigmin (TN)
- Vagostigmin (TN)
- [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
- [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
- [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
- Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
- Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-(9CI)
- (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
Reported adverse events
- Hypersensitivity
- Bradycardia
- Bronchospasm
- Cardiac arrest
- Dizziness
- Dry mouth
- Arthralgia
- Insomnia
- Rash
- Incision site complication
Look up NEOSTIGMINE in the interactive SynDRA portal →